...
首页> 外文期刊>World journal of gastroenterology : >Simultaneous follow-up of mouse colon lesions by colonoscopy and endoluminal ultrasound biomicroscopy
【24h】

Simultaneous follow-up of mouse colon lesions by colonoscopy and endoluminal ultrasound biomicroscopy

机译:通过结肠镜检查和腔内超声生物显微镜同时追踪小鼠结肠病变

获取原文
获取原文并翻译 | 示例

摘要

AIM: To evaluate the potential use of colonoscopy and endoluminal ultrasonic biomicroscopy (eUBM) to track the progression of mouse colonic lesions. METHODS: Ten mice were treated with a single azoxymethane intraperitoneal injection (week 1) followed by seven days of a dextran sulfate sodium treatment in their drinking water (week 2) to induce inflammationassociated colon tumors. eUBM was performed simultaneously with colonoscopy at weeks 13, 17-20 and 21. A 3.6-F diameter 40 MHz mini-probe catheter was used for eUBM imaging. The ultrasound mini-probe catheter was inserted into the accessory channel of a pediatric flexible bronchofiberscope, allowing simultaneous acquisition of colonoscopic and eUBM images. During image acquisition, the mice were anesthetized with isoflurane and kept in a supine position over a stainless steel heated surgical waterbed at 37 °C. Both eUBM and colonoscopic images were captured and stored when a lesion was detected by colonoscopy or when the eUBM image revealed a modified colon wall anatomy. During the procedure, the colon was irrigated with water that was injected through a flush port on the mini-probe catheter and that acted as the ultrasound coupling medium between the transducer and the colon wall. Once the acquisition of the last eUBM/colonoscopy section for each animal was completed, the colons were fixed, paraffin-embedded, and stained with hematoxylin and eosin. Colon images acquired at the first time-point for each mouse were compared with subsequent eUBM/colonoscopic images of the same sites obtained in the following acquisitions to evaluate lesion progression. RESULTS: All 10 mice had eUBM and colonoscopic images acquired at week 13 (the first time-point). Two animals died immediately after the first imaging acquisition and, consequently, only 8 mice were subjected to the second eUBM/colonoscopy imaging acquisition (at the second time-point). Due to the advanced stage of colonic tumorigenesis, 5 animals died after the second time-point image acquisition, and thus, only three were subjected to the third eUBM/colonoscopy imaging acquisition (the third time-point). eUBM was able to detect the four layers in healthy segments of colon: the mucosa (the first hyperechoic layer moving away from the mini-probe axis), followed by the muscularis mucosae (hypoechoic), the submucosa (the second hyperechoic layer) and the muscularis externa (the second hypoechoic layer). Hypoechoic regions between the mucosa and the muscularis externa layers represented lymphoid infiltrates, as confirmed by the corresponding histological images. Pedunculated tumors were represented by hyperechoic masses in the mucosa layer. Among the lesions that decreased in size between the first and third time-points, one of the lesions changed from a mucosal hyperplasia with ulceration at the top to a mucosal hyperplasia with lymphoid infiltrate and, finally, to small signs of mucosal hyperplasia and lymphoid infiltrate. In this case, while lesion regression and modification were observable in the eUBM images, colonoscopy was only able to detect the lesion at the first and second time-points, without the capacity to demonstrate the presence of lymphoid infiltrate. Regarding the lesions that increased in size, one of them started as a small elevation in the mucosa layer and progressed to a pedunculated tumor. In this case, while eUBM imaging revealed the lesion at the first time-point, colonoscopy was only able to detect it at the second time-point. All colonic lesions (tumors, lymphoid infiltrate and mucosal thickening) were identified by eUBM, while colonoscopy identified just 76% of them. Colonoscopy identified all of the colonic tumors but failed to diagnose lymphoid infiltrates and increased mucosal thickness and failed to differentiate lymphoid infiltrates from small adenomas. During the observation period, most of the lesions (approximately 67%) increased in size, approximately 14% remained unchanged, and 19% regressed
机译:目的:评估结肠镜检查和腔内超声生物显微镜(eUBM)在跟踪小鼠结肠病变进展中的潜在用途。方法:对十只小鼠进行单次腹腔注射乙氧基甲烷腹腔注射(第1周),然后在其饮用水中进行7天硫酸葡聚糖钠治疗(第2周),以诱发炎症相关的结肠肿瘤。在第13、17-20和21周与结肠镜检查同时进行eUBM。将直径为3.6-F的40 MHz小探针导管用于eUBM成像。将超声微型探头导管插入到儿科柔性纤维支气管镜的附属通道中,从而可以同时采集结肠镜和eUBM图像。在图像采集期间,将小鼠用异氟烷麻醉,并在37°C的不锈钢加热手术水床上保持仰卧位。当通过结肠镜检查发现病变或当eUBM图像显示结肠壁解剖结构改变时,会捕获并存储eUBM和结肠镜检查图像。在此过程中,结肠用水冲洗,该水通过微型探头导管上的冲洗端口注入,并充当换能器和结肠壁之间的超声耦合介质。一旦完成对每只动物的最后一个eUBM /结肠镜检查部分的采集,就将结肠固定,石蜡包埋并用苏木精和曙红染色。将在每只小鼠的第一个时间点获取的结肠图像与在随后的获取中获得的相同部位的后续eUBM /结肠镜图像进行比较,以评估病变的进展。结果:所有10只小鼠均在第13周(第一个时间点)获得了eUBM和结肠镜检查图像。第一次采集图像后立即有两只动物死亡,因此,只有8只小鼠进行了第二次eUBM /结肠镜检查图像采集(在第二个时间点)。由于结肠肿瘤发生的晚期,在第二时间点图像采集之后有5只动物死亡,因此,只有三只动物进行了第三次eUBM /结肠镜检查成像(第三时间点)。 eUBM能够检测到结肠健康段中的四层:粘膜(从小探针轴移开的第一高回声层),然后是肌层粘膜(低回声),粘膜下层(第二高回声层)和外部肌层(第二低回声层)。粘膜和外肌层之间的低回声区代表淋巴样浸润,如通过相应的组织学图像所证实。有蒂的肿瘤以粘膜层的高回声肿块为代表。在第一个和第三个时间点之间大小减小的病变中,其中一个病变从顶部溃疡的粘膜增生变为淋巴样浸润的粘膜增生,最后变为粘膜增生和淋巴样浸润的小体征。在这种情况下,尽管在eUBM图像中可以观察到病变消退和改变,但结肠镜检查只能在第一和第二个时间点检测到病变,而无法证明淋巴样浸润的存在。关于增大的病变,其中之一开始于粘膜层的小隆起,并发展为有蒂的肿瘤。在这种情况下,尽管eUBM成像在第一个时间点显示病变,但结肠镜检查只能在第二个时间点检测到病变。通过eUBM可以识别所有结肠病变(肿瘤,淋巴样浸润和粘膜增厚),而结肠镜检查仅能识别其中的76%。结肠镜检查发现了所有结肠肿瘤,但未能诊断出淋巴样浸润和粘膜厚度增加,也未能区分淋巴样浸润与小腺瘤。在观察期间,大多数病变(约67%)增大,约14%不变,而19%消退

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号